Trials / Completed
CompletedNCT04689932
Triferic AVNU Infusion Via Freedom Pump During Hemodialysis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Rockwell Medical Technologies, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate the delivery of Triferic AVNU intravenously using the Freedom Pump-20 during hemodialysis into the pre-dialyzer and post-dialyzer blood lines.
Detailed description
This is a single center, multi dose, open label study assessing the delivery of Triferic AVNU administered intravenously to adult patients (\> or equal to 18 years of age) using the Freedom Pump-20 during hemodialysis into the pre-dialyzer and post-dialyzer blood lines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triferic AVNU | Ferric Pyrophosphate Citrate |
Timeline
- Start date
- 2021-04-19
- Primary completion
- 2021-06-19
- Completion
- 2021-06-19
- First posted
- 2020-12-30
- Last updated
- 2022-02-28
- Results posted
- 2022-01-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04689932. Inclusion in this directory is not an endorsement.